Aroa Biosurgery Company Description
Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; Myriad Morcells Fine that delivers a bolus of biologically important ECM proteins to help kick start and sustain healing; and Symphony, a combination cellular and tissue product, indicated for the regeneration of functional tissue in complex wounds.
The company also develops products for abdominal wall reconstruction, hernia repair, and breast reconstruction in North America and Europe.
Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand.
| Country | New Zealand |
| Founded | 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Brian Ward |
Contact Details
Address: 64 Richard Pearse Drive Auckland, 2022 New Zealand | |
| Phone | 64 9 869 3035 |
| Website | aroa.com |
Stock Details
| Ticker Symbol | AROAF |
| Exchange | OTCMKTS |
| Fiscal Year | April - March |
| Reporting Currency | NZD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Brian Ward B.V.Sc, MBA(dist) | Founder, Chief Executive Officer, MD and Executive Director |
| James Agnew BCom, LLB | Chief Financial Officer and Joint Company Secretary |
| Dr. Barnaby C.H. May Ph.D. | Chief Scientific Officer |
| Neetha Alex-Kumar | General Counsel |
| Frazer Murray | Director of Global Marketing and Strategy |
| Tracy Weimar BA, MBA | Joint Company Secretary |
| Adam Young Ph.D. | Vice President of Medical Affairs |